Ceria nanoparticles ameliorate renal fibrosis by modulating the balance between oxidative phosphorylation and aerobic glycolysis
<strong>Background and aims<br></strong> Renal fibrosis is the common outcome in all progressive forms of chronic kidney disease. Unfortunately, the pathogenesis of renal fibrosis remains largely unexplored, among which metabolic reprogramming plays an extremely crucial role in the...
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
BioMed Central
2022
|
| _version_ | 1824458780664922112 |
|---|---|
| author | Wang, M Zeng, F Ning, F Wang, Y Zhou, S He, J Li, C Wang, C Sun, X Zhang, D Xiao, J Hu, P Reilly, S Xin, H Xu, X Zhang, X |
| author_facet | Wang, M Zeng, F Ning, F Wang, Y Zhou, S He, J Li, C Wang, C Sun, X Zhang, D Xiao, J Hu, P Reilly, S Xin, H Xu, X Zhang, X |
| author_sort | Wang, M |
| collection | OXFORD |
| description | <strong>Background and aims<br></strong>
Renal fibrosis is the common outcome in all progressive forms of chronic kidney disease. Unfortunately, the pathogenesis of renal fibrosis remains largely unexplored, among which metabolic reprogramming plays an extremely crucial role in the evolution of renal fibrosis. Ceria nanoparticles (CeNP-PEG) with strong ROS scavenging and anti-inflammatory activities have been applied for mitochondrial oxidative stress and inflammatory diseases. The present study aims to determine whether CeNP-PEG has therapeutic value for renal fibrosis.
<br><strong>
Methods<br></strong>
The unilateral ureteral obstructive fibrosis model was used to assess the therapeutic effects in vivo. Transforming growth factor beta1-induced epithelial-to-mesenchymal transition in HK-2 cells was used as the in vitro cell model. The seahorse bioscience X96 extracellular flux analyzer was used to measure the oxygen consumption rate and extracellular acidification rate.
<br><strong>
Results<br></strong>
In the present study, CeNP-PEG treatment significantly ameliorated renal fibrosis by increased E-cadherin protein expression, and decreased α-SMA, Vimentin and Fibronectin expression both in vitro and in vivo. Additionally, CeNP-PEG significantly reduced the ROS formation and improved the levels of mitochondrial ATP. The seahorse analyzer assay demonstrated that the extracellular acidification rate markedly decreased, whereas the oxygen consumption rate markedly increased, in the presence of CeNP-PEG. Furthermore, the mitochondrial membrane potential markedly enhanced, hexokinase 1 and hexokinase 2 expression significantly decreased after treatment with CeNP-PEG.
<br><strong>
Conclusions<br></strong>
CeNP-PEG can block the dysregulated metabolic status and exert protective function on renal fibrosis. This may provide another therapeutic option for renal fibrosis. |
| first_indexed | 2024-03-07T07:36:09Z |
| format | Journal article |
| id | oxford-uuid:3f295733-4dcb-440f-870e-caf3daba2dc0 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2025-02-19T04:31:20Z |
| publishDate | 2022 |
| publisher | BioMed Central |
| record_format | dspace |
| spelling | oxford-uuid:3f295733-4dcb-440f-870e-caf3daba2dc02025-01-10T20:03:52ZCeria nanoparticles ameliorate renal fibrosis by modulating the balance between oxidative phosphorylation and aerobic glycolysisJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:3f295733-4dcb-440f-870e-caf3daba2dc0EnglishSymplectic ElementsBioMed Central2022Wang, MZeng, FNing, FWang, YZhou, SHe, JLi, CWang, CSun, XZhang, DXiao, JHu, PReilly, SXin, HXu, XZhang, X<strong>Background and aims<br></strong> Renal fibrosis is the common outcome in all progressive forms of chronic kidney disease. Unfortunately, the pathogenesis of renal fibrosis remains largely unexplored, among which metabolic reprogramming plays an extremely crucial role in the evolution of renal fibrosis. Ceria nanoparticles (CeNP-PEG) with strong ROS scavenging and anti-inflammatory activities have been applied for mitochondrial oxidative stress and inflammatory diseases. The present study aims to determine whether CeNP-PEG has therapeutic value for renal fibrosis. <br><strong> Methods<br></strong> The unilateral ureteral obstructive fibrosis model was used to assess the therapeutic effects in vivo. Transforming growth factor beta1-induced epithelial-to-mesenchymal transition in HK-2 cells was used as the in vitro cell model. The seahorse bioscience X96 extracellular flux analyzer was used to measure the oxygen consumption rate and extracellular acidification rate. <br><strong> Results<br></strong> In the present study, CeNP-PEG treatment significantly ameliorated renal fibrosis by increased E-cadherin protein expression, and decreased α-SMA, Vimentin and Fibronectin expression both in vitro and in vivo. Additionally, CeNP-PEG significantly reduced the ROS formation and improved the levels of mitochondrial ATP. The seahorse analyzer assay demonstrated that the extracellular acidification rate markedly decreased, whereas the oxygen consumption rate markedly increased, in the presence of CeNP-PEG. Furthermore, the mitochondrial membrane potential markedly enhanced, hexokinase 1 and hexokinase 2 expression significantly decreased after treatment with CeNP-PEG. <br><strong> Conclusions<br></strong> CeNP-PEG can block the dysregulated metabolic status and exert protective function on renal fibrosis. This may provide another therapeutic option for renal fibrosis. |
| spellingShingle | Wang, M Zeng, F Ning, F Wang, Y Zhou, S He, J Li, C Wang, C Sun, X Zhang, D Xiao, J Hu, P Reilly, S Xin, H Xu, X Zhang, X Ceria nanoparticles ameliorate renal fibrosis by modulating the balance between oxidative phosphorylation and aerobic glycolysis |
| title | Ceria nanoparticles ameliorate renal fibrosis by modulating the balance between oxidative phosphorylation and aerobic glycolysis |
| title_full | Ceria nanoparticles ameliorate renal fibrosis by modulating the balance between oxidative phosphorylation and aerobic glycolysis |
| title_fullStr | Ceria nanoparticles ameliorate renal fibrosis by modulating the balance between oxidative phosphorylation and aerobic glycolysis |
| title_full_unstemmed | Ceria nanoparticles ameliorate renal fibrosis by modulating the balance between oxidative phosphorylation and aerobic glycolysis |
| title_short | Ceria nanoparticles ameliorate renal fibrosis by modulating the balance between oxidative phosphorylation and aerobic glycolysis |
| title_sort | ceria nanoparticles ameliorate renal fibrosis by modulating the balance between oxidative phosphorylation and aerobic glycolysis |
| work_keys_str_mv | AT wangm ceriananoparticlesamelioraterenalfibrosisbymodulatingthebalancebetweenoxidativephosphorylationandaerobicglycolysis AT zengf ceriananoparticlesamelioraterenalfibrosisbymodulatingthebalancebetweenoxidativephosphorylationandaerobicglycolysis AT ningf ceriananoparticlesamelioraterenalfibrosisbymodulatingthebalancebetweenoxidativephosphorylationandaerobicglycolysis AT wangy ceriananoparticlesamelioraterenalfibrosisbymodulatingthebalancebetweenoxidativephosphorylationandaerobicglycolysis AT zhous ceriananoparticlesamelioraterenalfibrosisbymodulatingthebalancebetweenoxidativephosphorylationandaerobicglycolysis AT hej ceriananoparticlesamelioraterenalfibrosisbymodulatingthebalancebetweenoxidativephosphorylationandaerobicglycolysis AT lic ceriananoparticlesamelioraterenalfibrosisbymodulatingthebalancebetweenoxidativephosphorylationandaerobicglycolysis AT wangc ceriananoparticlesamelioraterenalfibrosisbymodulatingthebalancebetweenoxidativephosphorylationandaerobicglycolysis AT sunx ceriananoparticlesamelioraterenalfibrosisbymodulatingthebalancebetweenoxidativephosphorylationandaerobicglycolysis AT zhangd ceriananoparticlesamelioraterenalfibrosisbymodulatingthebalancebetweenoxidativephosphorylationandaerobicglycolysis AT xiaoj ceriananoparticlesamelioraterenalfibrosisbymodulatingthebalancebetweenoxidativephosphorylationandaerobicglycolysis AT hup ceriananoparticlesamelioraterenalfibrosisbymodulatingthebalancebetweenoxidativephosphorylationandaerobicglycolysis AT reillys ceriananoparticlesamelioraterenalfibrosisbymodulatingthebalancebetweenoxidativephosphorylationandaerobicglycolysis AT xinh ceriananoparticlesamelioraterenalfibrosisbymodulatingthebalancebetweenoxidativephosphorylationandaerobicglycolysis AT xux ceriananoparticlesamelioraterenalfibrosisbymodulatingthebalancebetweenoxidativephosphorylationandaerobicglycolysis AT zhangx ceriananoparticlesamelioraterenalfibrosisbymodulatingthebalancebetweenoxidativephosphorylationandaerobicglycolysis |